BSE filing, BSE: 544673. Summary written from the filing by ALFA Finder's alert engine.
Modern Diagnostic & Research Centre Ltd: key numbers
- Share price
- ₹59.30
- Market cap
- ₹89.54 Cr
- Revenue (annual)
- ₹83.11 Cr
- Net profit (annual)
- ₹5.25 Cr
- P/E (TTM)
- 17.0×Sector 52.0×
- Promoter holding
- 72.95%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Modern Diagnostic & Research Centre Ltd
All →Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited conducted its 14th AGM on September 30, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and auditor reappointment.
Modern Diagnostic & Research Centre Price Movement Clarification
Modern Diagnostic & Research Centre Ltd clarified its share price movement is purely market-driven. No undisclosed or price-sensitive information exists requiring disclosure under SEBI Regulations.
Modern Diagnostic & Research Centre Annual Report
Modern Diagnostic & Research Centre has submitted its Annual Report and Notice of the 14th Annual General Meeting for the financial year 2025-26.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited has scheduled its 14th Annual General Meeting for September 30, 2026. The book closure is from September 24 to 30.
Modern Diagnostic & Research Centre Board Meeting Outcome
Modern Diagnostic & Research Centre approved various routine matters, including AGM notice, director reappointment, and statutory auditor reappointment. It also terminated a Jaipur laboratory management agreement.
Modern Diagnostic & Research Centre Board Meeting Date
Modern Diagnostic & Research Centre Limited scheduled a board meeting for September 3, 2026, to discuss administrative agenda items including AGM notices and reports.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.